Minimal stimulation in the IVF/ICSI+ET programme
Authors:
MUDr. Jiří Dostál, Ph.D.; RNDr. Jana Březinová; Mgr. Magda Svobodová
Authors‘ workplace:
Centrum asistované reprodukce, Porodnicko-gynekologická klinika, LF UP a FN Olomouc
Published in:
Prakt Gyn 2005; 9(2): 10-12
Overview
New stimulation protocols in the in vitro fertilization/intracytoplasmic sperm injection and embryotransfer (IVF/ICSI+ET) programme bring into a part of treated infertile couples the increased risc of complications and increased expenses. Minimal stimulation is cheeper than standard stimulation. Her satisfactory results in pregancy rates per ovum pick-up and ET are an attractive alternative for younger patients with tubal factor infertility, who do not realize the conditions for treatment insurance coverage.
Key words:
minimal stimulation - in vitro fertilization - embryotransfer.
Sources
1. Steptoe PC, Edwards RG. Birth after re-implatation of a human embryo. Lancet 1978; 2: 366.
2. Adashi EY. Clomiphen citrate: Mechanism(s) and site(s) of action-a hypothesis revisited. Fertil Steril 1984; 42: 331-343.
3. Jones HW jr, Acosta AA, Andrews MC et al. Three years of in vitro fertilization at Norfolk. Fertil Steril 1984; 42: 826-834.
4. Diamond MP, Hill GA, Webster BW et al. Comparison of human menopausal gonadotropin, clomiphene citrate, and combined human menopausal gonadotropin-clomiphene citrate stimulation protocols for in vitro fertilization. Fertil Steril 1986; 46: 1108-1112.
5. Liu HC, Lai YM, Davis O et al. Improved pregnancy outcome with gonadotropin releasing hormone agonist stimulation is due to the imrpovement in oocyte quantity raher than quality. J Assist Reprod Genet 1992; 9: 338-344.
6. Diedrich K, Diedrich C, Santos E et al. Supression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod 1994; 9: 788-791.
7. Paulson RJR, Sauer MV, Francis MM et al. In vitro fertilization in unstimulated cycles: the University of Southern California experience. Fertil Steril 1992; 57: 290-293.
8. Foulot H, Ranoux C, Dubuisson JB et al. In vitro fertilization without ovarian stimulation: a simplified protocol applied in 80 cycles. Fertil Steril 1989; 52: 617-621.
9. Corfman RS, Milad MP, Bellavance TL et al. A novel ovarian stimulation protocol for use with assisted reproductive technologies. Fertil Steril 1993; 60: 864-870.
10. Williams SC, Gibbons WE, Musher SJ et al. Minimal ovarian hyperstimulation for in vitro fertilization using sequential climiphene citrate and gonadotropin with or without the addition of a gonadotropin-releasing hormone antagonist. Fertil Steril 2002; 78: 1068-1072.
11. Oborná I, Talaš M, Dostál J et al. Hodnocení výsledků IVF+ET za roky 1992–1995 na gyn.-por. klinice v Olomouci, srovnání stimulačních protokolů. Čes Gynek 1996; 61: 349-351.
12. Reynolds AM, Schieve LA, Jeng G et al. Does insurance coverage decrease the risk for multiple births associated with assisted reproductive technology? Fertil Steril 2003; 80: 16-23.
13. Jain J, Harlow BL, Hornstein MD. Insurance coverage and outcomes of in vitro fertilization. N Engl J Med 2002; 347: 661-666.
Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicineArticle was published in
Practical Gynecology
2005 Issue 2
Most read in this issue
- Chlamydias in ejaculate; the influence on the quality and morphology of sperms
- Developmental defects in reproduction losses in the 1st trimester of pregnancy
- Minimal stimulation in the IVF/ICSI+ET programme
- Controversions in perimenopause and postmenopause